A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Clinical trial NCT05862272 · RECRUITING
Trial details
- NCT number
- NCT05862272
- Sponsor
- Sumitomo Pharma Switzerland GmbH
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2029-07-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.